Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 2005;112:2235-2244
Published online before print October 3, 2005, doi: 10.1161/CIRCULATIONAHA.105.547893
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
112/15/2235    most recent
CIRCULATIONAHA.105.547893v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by van Veen, T. A.B.
Right arrow Articles by de Bakker, J. M.T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by van Veen, T. A.B.
Right arrow Articles by de Bakker, J. M.T.
Related Collections
Right arrow Structure
Right arrow Arrythmias-basic studies

(Circulation. 2005;112:2235-2244.)
© 2005 American Heart Association, Inc.


Arrhythmia/Electrophysiology

Discontinuous Conduction in Mouse Bundle Branches Is Caused by Bundle-Branch Architecture

Toon A.B. van Veen, PhD; Harold V.M. van Rijen, PhD; Marjan J.A. van Kempen, PhD; Lucile Miquerol, PhD; Tobias Opthof, PhD; Daniel Gros, PhD; Marc A. Vos, PhD; Habo J. Jongsma, PhD; Jacques M.T. de Bakker, PhD

From the Department of Medical Physiology, University Medical Center Utrecht, Utrecht, the Netherlands (T.A.B.v.V., H.V.M.v.R., M.J.A.v.K., T.O., M.A.V., H.J.J.); Institute of Developmental Biology of Marseilles and UMR/CNRS 6545, University de la Mediterranee, Marseille, France (L.M., D.G.); Interuniversity Cardiology Institute of the Netherlands and Heart Lung Center Utrecht, University Medical Center Utrecht, Utrecht, the Netherlands (J.M.T.d.B.); and Experimental and Molecular Cardiology Group, Academic Medical Center, Amsterdam, the Netherlands (T.O., J.M.T.d.B.).

Correspondence to Toon A.B. van Veen, PhD, Department of Medical Physiology, University Medical Center Utrecht, A. Numan Bldg, Yalelaan 50, 3584 CM Utrecht, The Netherlands. E-mail A.A.B.vanVeen{at}med.uu.nl

Received March 8, 2005; revision received July 12, 2005; accepted July 19, 2005.

Background— Recordings of the electrical activity of mouse bundle branches (BBs) suggest reduced conduction velocity (CV) in the midseptal compared with the proximal part of the BB. The present study was performed to elucidate the mechanism responsible for this slowing of conduction.

Methods and Results— Hearts of 16 mice were isolated and Langendorff perfused. After the right and left ventricular free walls were removed, the extracellular activity of the BB was mapped with a 247-point electrode. Premature stimulation was used to estimate CV restitution in the BBs. Expression/distribution of connexin40 (Cx40), Cx43, and Cx45 was determined. Morphology of the conduction system was assessed by whole-mount acetylcholine esterase staining and in Cx40+/KI-GFP hearts. Effective CV in the midseptal part of the left and right BBs was reduced by 50% compared with the proximal BB. CV restitution in the proximal and midseptal parts of the BBs was similar. Myocytes labeled positive for Cx40 and Cx45 in the entire BB. Cx43 colocalized with Cx40 and Cx45 only in the very distal BB. Subcellular distribution of gap junctions differed between proximal and distal BBs. Geometry of the midseptal and distal BBs revealed on both sides a profuse network of interlacing fibers, whereas the proximal BB consisted of a single (right BB) or multiple (left BB) parallel fibers.

Conclusions— Comparison of connexin expression/distribution, geometry of the BBs, and CV characteristics suggests that increased path length for activation resulting from BB geometry is responsible for the apparently reduced CV in the midseptal BB of the mouse heart.


 

CLINICAL PERSPECTIVE